HIV-Associated Cardiovascular Disease: Role of Connexin 43

Area of Science:

• Cardiovascular pathology
• HIV research
• Molecular cardiology

Background:

• Effective antiretroviral treatment for chronic HIV infection has led to increased longevity but also a higher incidence of cardiovascular diseases.
• The mechanisms linking HIV infection to accelerated heart disease remain poorly understood.
• HIV-infected individuals exhibit a 1.5 to 2 times greater risk of cardiovascular diseases compared to uninfected individuals.

Purpose of the Study:

• To investigate the role of connexin 43 (Cx43) and inflammation in the pathogenesis of cardiovascular complications in HIV-infected individuals.
• To examine Cx43 expression and distribution in postmortem human heart tissues from HIV-infected and control subjects.

Main Methods:

• Analysis of postmortem human heart tissues from HIV-infected and control uninfected individuals.
• Examination of connexin 43 (Cx43) expression, localization, and associated cardiac cellular changes.
• Assessment of viral replication, CD4 counts, inflammation, and antiretroviral treatment history.

Main Results:

• Connexin 43 (Cx43) was found to be dysregulated in HIV-infected heart tissues, with areas of overexpression along cardiomyocyte lateral membranes and intercalated disks.
• Anomalous Cx43 expression and localization correlated with calcium overload, sarcofilamental atrophy, and collagen accumulation.
• These cardiac alterations were observed irrespective of viral replication, CD4 counts, inflammation, or antiretroviral therapy.

Conclusions:

• HIV infection leads to increased Cx43 expression in the heart.
• This Cx43 dysregulation results in cardiac tissue damage, including cellular changes and fibrosis.
• The study proposes that HIV-induced Cx43 alterations contribute significantly to the elevated rates of cardiovascular disease in HIV-infected individuals.